Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...
What Happened: The latest Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission uncovered Walter, SVP at Medtronic, exercising stock options for 1,337 shares of MDT. The total ...
What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission, Martha, Chairman and CEO at Medtronic, executed a strategic derivative sale. This involved ...